Kayne Anderson Rudnick Investment Management
MYOV

Kayne Anderson Rudnick Investment Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-97
Closed -$1K – 698
2022
Q1 		$1K Buy
+97
New +$1.3K ﹤0.01% 652

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's MYOV Position: Q2 2022 in Review

Kayne Anderson Rudnick Investment Management sold out of Myovant Sciences Ltd. (MYOV) in Q2 2022, closing a stake of 97 shares — an estimated $1K sold.

Kayne Anderson Rudnick Investment Management first reported a position in MYOV in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 91 funds tracked by Wall St. Rank hold MYOV as of Q2 2022.

  • Kayne Anderson Rudnick Investment Management reported no remaining Myovant Sciences Ltd. position as of Q2 2022 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 97 Myovant Sciences Ltd. shares in Q2 2022, an estimated $1K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Myovant Sciences Ltd. in Q1 2022 and held it in 1 quarter.
  • Kayne Anderson Rudnick Investment Management's Myovant Sciences Ltd. position peaked at $1K in Q1 2022.
  • 91 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2022.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.